Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy
Open Access
- 6 October 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10800
Abstract
The advent of T-cell-based immunotherapy has remarkably transformed cancer patient treatment. Despite their success, the currently approved immunotherapeutic protocols still encounter limitations, cause toxicity, and give disparate patient outcomes. Thus, a deeper understanding of the molecular mechanisms of T-cell activation and inhibition is much needed to rationally expand targets and possibilities to improve immunotherapies. Protein ubiquitination downstream of immune signaling pathways is essential to fine-tune virtually all immune responses, in particular, the positive and negative regulation of T-cell activation. Numerous studies have demonstrated that deregulation of ubiquitin-dependent pathways can significantly alter T-cell activation and enhance antitumor responses. Consequently, researchers in academia and industry are actively developing technologies to selectively exploit ubiquitin-related enzymes for cancer therapeutics. In this review, we discuss the molecular and functional roles of ubiquitination in key T-cell activation and checkpoint inhibitory pathways to highlight the vast possibilities that targeting ubiquitination offers for advancing T-cell-based immunotherapies.Keywords
Funding Information
- Vetenskapsrådet (NE 2016-04458)
- Ragnar Söderbergs stiftelse (M21/17)
This publication has 264 references indexed in Scilit:
- Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspectsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- E3 Ubiquitin Ligase Cbl-b Regulates Pten via Nedd4 in T Cells Independently of Its Ubiquitin Ligase ActivityCell Reports, 2012
- Ablation of Smurf2 reveals an inhibition in TGF‐β signalling through multiple mono‐ubiquitination of Smad3The EMBO Journal, 2011
- PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8+ T cellsEMBO Molecular Medicine, 2011
- Ubiquitin Makes Its Mark on Immune RegulationImmunity, 2010
- Deubiquitinases in the regulation of NF-κB signalingCell Research, 2010
- K33-Linked Polyubiquitination of T Cell Receptor-ζ Regulates Proteolysis-Independent T Cell SignalingImmunity, 2010
- The E3 Ubiquitin Ligase GRAIL Regulates T Cell Tolerance and Regulatory T Cell Function by Mediating T Cell Receptor-CD3 DegradationImmunity, 2010
- CD28− T cells: their role in the age-associated decline of immune functionTrends in Immunology, 2009
- What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?Journal of Molecular Evolution, 2009